Evidence map›Paper›PMID 36426229›Full record

ArticleFrontiers in cardiovascular medicine2022

Lubin Li, Guolong Liu, Benxiang Yu, Wenqiang Niu, Zhigang Pei, Juwen Zhang, Haijie Che, Fubo Song, Mu Yang

Open access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in cardiovascular medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Lubin LiDepartment of Vascular Surgery, Yantai Yuhuangding Hospital, Yantai, China.
Guolong LiuDepartment of Vascular Surgery, Yantai Yuhuangding Hospital, Yantai, China.
Benxiang YuDepartment of Vascular Surgery, Yantai Yuhuangding Hospital, Yantai, China.
Wenqiang NiuDepartment of Vascular Surgery, Yantai Yuhuangding Hospital, Yantai, China.
Zhigang PeiDepartment of Vascular Surgery, Yantai Yuhuangding Hospital, Yantai, China.
Juwen ZhangDepartment of Vascular Surgery, Yantai Yuhuangding Hospital, Yantai, China.
Haijie CheDepartment of Vascular Surgery, Yantai Yuhuangding Hospital, Yantai, China.
Fubo SongDepartment of Vascular Surgery, Yantai Yuhuangding Hospital, Yantai, China.
Mu YangDepartment of Vascular Surgery, Yantai Yuhuangding Hospital, Yantai, China.
Yuhuangding Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Infected abdominal aortic and iliac artery aneurysms are considered acute and severe diseases with insidious onset, rapid development, and high mortality in vascular surgery. Currently, there is no better treatment, either anatomic or extra-anatomical repair. Case presentation: From February 2018 to April 2022, 7 patients with infected abdominal aortic and iliac artery aneurysms did not have sufficient autologous venous material for repair. With the consent of the Ethics Committee of the hospital, it uses the autologous peritoneal fascial tissue with rectus sheath to repair or reconstruct the infected vessels Conclusion:

Indexed as

autologous fascia-peritoneum with posterior rectus sheathinfected aneurysmin situreconstructionrepair

Identifiers

PMID36426229
PMCPMC9679408
OpenAlexW4308424580

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.